Are Options Traders Bullish on AERI?
Let daily Option Order Flow show you where stock investors are Bullish and Bearish!!! Receive a FREE daily email of the Market Chameleon Order Flow Sentiment Newsletter.
Market Chameleon
Aerie Pharmaceuticals Inc.

AERI

73.40

-0.50

-0.7%

After Hours:

73.40

0.00

0.0%

Please Login or Register

Login|Register FREE

Please Login or Register

Login|Register FREE

Stock Price
Open: 74.15
Prev. Close: 73.90
Low/Hi: 73.25 - 74.75
52-Week: 47.05 - 74.60
Volumes
Equity: 245,057
90-Day Avg: 359,312
Option: 72
90-Day Avg: 358
Volatility
Todays Stock Vol: 19.0
20-Day (HV): 37.4
52-Week (HV): 44.2
30-Day IV: 44.7 -2.6
IV Pct Rank: 21% Subdued
Fundamental
Div. Yield:
Earnings: 1-Aug (Est.)
P/E Ratio:
Market Cap: 2.9 B
Short Int Pct: 0.0%
Pct Held By Inst.: 96.7%
Stock Info
Type: Common
Sector: Healthcare
Industry: Drug Manufacturers - Major

About AERI

Aerie is a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with glaucoma and other diseases of the eye. Aerie recently reported the successful results of its second Phase 3 registration trial in the United States named Rocket 2, where the primary efficacy endpoint was to demonstrate non-inferiority of IOP lowering for Rhopressa compared to timolol. Rocket 3, a 12-month safety-only study, is currently in progress, and Aerie has recently commenced a fourth Phase 3 trial for Rhopressa, named Rocket 4. Aerie also completed in 2014 a Phase 2b clinical trial in which Roclatan met the primary efficacy endpoint, demonstrating the statistical superiority of Roclatan to each of its components, and recently commenced the first Phase 3 registration trial for Roclatan, named Mercury 1. Aerie also recently announced research collaborations with GrayBug, Inc. and Ramot at Tel Aviv University as it further builds its pipeline for future growth.
Primary Exchange: NASDAQ
SIC Biological Products, (No Diagnostic Substances)
NAICS Pharmaceutical Preparation Manufacturing

AERI is a Holding In These ETFs:

ETF Ticker ETF Name Net Assets Net Assets Raw # Holdings # Holdings Raw Weight Weight Raw Market Value Market Value Raw
BIB ProShares Ultra Nasdaq Biotechnology 367.9 M 3.6791E+08 203 203 0.13% 0.001282 1.0 M 1039550
EQWS Invesco Russell 2000 Equal Weight ETF 26.0 M 2.6E+07 1,986 1986 0.03% 0.00034 9 K 8832
FHLC Fidelity MSCI Health Care Index ETF 1.2 B 1.2E+09 354 354 0.06% 0.00063243 782 K 782074
IBB iShares Nasdaq Biotechnology Index Fund 9.6 B 9.59496E+09 192 192 0.35% 0.0035 33.8 M 3.37685E+07
IHE iShares U.S. Pharmaceutical ETF 388.4 M 3.884E+08 43 43 1.82% 0.0182 7.1 M 7063320
ITOT iShares Core S&P Total U.S. Stock Market ETF 14.9 B 1.49391E+10 3,452 3452 0.01% 0.0001 1.5 M 1536960
IWM iShares Russell 2000 ETF 47.5 B 4.7459E+10 2,018 2018 0.12% 0.0012 53.8 M 5.38026E+07
IWO iShares Russell 2000 Growth ETF 11.2 B 1.12322E+10 1,220 1220 0.23% 0.0023 25.5 M 2.55309E+07
IWV iShares Russell 3000 ETF 9.6 B 9.62607E+09 3,003 3003 0.01% 0.0001 862 K 861635
JKK iShares Morningstar Small-Cap Growth ETF 207.2 M 2.07181E+08 254 254 0.42% 0.0042 877 K 876502
ONEQ Fidelity Nasdaq Composite Index Tracking Stock 1.9 B 1.9E+09 973 973 0.04% 0.00036246 703 K 702586
PTH Invesco DWA Healthcare Momentum ETF 262.7 M 2.627E+08 50 50 1.93% 0.01929 5.0 M 5049402
SBIO ALPS Medical Breakthroughs ETF 229.2 M 2.29153E+08 115 115 1.85% 0.0185 4.2 M 4239330
TILT FlexShares Mornigstar US Market Factors Tilt Index Fund ETF 1.3 B 1.29328E+09 1,908 1908 0.01% 6.4E-05 82 K 81660
UBIO Proshares UltraPro Nasdaq Biotechnology 33.1 M 3.30685E+07 197 197 0.06% 0.000572954 65 K 65254
URTY ProShares UltraPro Russell2000 182.0 M 1.82002E+08 2,028 2028 0.02% 0.00021816 134 K 133685
UWM ProShares Ultra Russell2000 260.1 M 2.60074E+08 2,028 2028 0.04% 0.000390921 228 K 228129
XPH SPDR S&P Pharmaceuticals ETF 345.8 M 3.4582E+08 45 45 1.59% 0.0158901 5.5 M 5494092

Wait, Before You Leave...